StonvexLoading…
StonvexCore line items from BBBY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $247.75M | $1.04B | $771.19M | $514.00M |
Operating Income | $-18.21M | $-61.21M | $-48.09M | $-35.64M |
Net Income | $-16.40M | $-84.62M | $-63.75M | $-59.23M |
EPS (Diluted) | $-0.24 | $-1.41 | $-1.11 | $-1.07 |
Total Assets | $404.45M | $425.48M | $414.38M | $358.07M |
Total Liabilities | $202.00M | $207.53M | $211.44M | $226.87M |
Cash & Equivalents | $135.83M | $175.29M | $167.37M | $120.55M |
Free Cash Flow OCF − CapEx | $-12.82M | $-64.11M | $-55.46M | $-38.09M |
Shares Outstanding | 69.36M | 68.86M | 64.98M | 57.41M |